Cargando…
Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain
BACKGROUND: The purpose of this study was to assess the economic impact of the fentanyl buccal tablet for the management of breakthrough cancer pain (BTcP) in Spain. METHODS: A 4-year budget impact model was developed for the period 2012–2015 for patients with BTcP from the perspective of the Spanis...
Autores principales: | Darbà, Josep, Kaskens, Lisette, Sánchez-de la Rosa, Rainel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869826/ https://www.ncbi.nlm.nih.gov/pubmed/24368889 http://dx.doi.org/10.2147/CEOR.S52273 |
Ejemplares similares
-
Fentanyl Buccal Tablet for the Treatment of Breakthrough Pain: Pharmacokinetics of Buccal Mucosa Delivery and Clinical Efficacy
por: Darwish, Mona, et al.
Publicado: (2010) -
A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
por: Freye, Enno
Publicado: (2008) -
Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain
por: Darbà, Josep, et al.
Publicado: (2015) -
Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS
por: Masel, Eva Katharina, et al.
Publicado: (2017) -
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
por: Darbà, Josep, et al.
Publicado: (2015)